A serum vitamin B12 test measures cobalamin, the form of vitamin B12 in blood, after a 6–8 hour fast, according to the U.S. National Library of Medicine. It can point to a reversible cause of confusion but cannot diagnose dementia type.
B12 shortage harms red-cell formation, myelin maintenance, and spinal and brain white matter, according to the MSD Manual Professional Edition. That damage can cause anemia, tingling, weakness, balance loss, and cognitive slowing. A second opinion therefore treats B12 as one exclusion step, not an answer by itself.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the blood draw measures
- Why dementia clinics order it routinely
- When borderline B12 needs MMA or homocysteine
- What a B12 result misses at a second opinion
What the blood draw measures
The test measures circulating cobalamin and is ordered for suspected megaloblastic or pernicious anemia, neuropathy, severe confusion, or dementia, according to the U.S. National Library of Medicine in the MedlinePlus vitamin B12 test article. Fasting for 6–8 hours is part of the standard collection.
Low B12 means the body lacks material for healthy red cells and nerve insulation. Tingling in hands or feet, weakness, unsteady walking, fatigue from anemia, and slowed thinking are typical warning patterns. These signs overlap with dementia, so the result needs clinical context.
Why dementia clinics order it routinely
Dementia assessment requires routine blood tests of liver, kidney, thyroid, glucose or HbA1c, vitamin B12, and folate to exclude reversible mimics before diagnosing dementia, according to the UK National Health Service in the NHS dementia tests guide. B12 and folate sit in that panel because shortage can mimic cognitive decline.
A normal B12 does not confirm Alzheimer's disease or another dementia. An abnormal B12 does not prove that B12 caused the cognitive change. The clinic must still weigh history, examination, and brain imaging.
When borderline B12 needs MMA or homocysteine
Methylmalonic acid testing detects functional shortage because B12 normally breaks down MMA, so high blood or urine MMA signals cellular shortage even when serum B12 is borderline, according to the U.S. National Library of Medicine in the MedlinePlus MMA test page. It helps when serum B12 falls in an uncertain range.
Homocysteine rises when B12-, B6-, or folate-dependent breakdown fails, so it flags B-vitamin shortage but cannot by itself prove B12 deficiency, according to the U.S. National Library of Medicine in the MedlinePlus homocysteine test page. Clinicians use it as supporting evidence, not a B12-specific diagnosis. Kidney failure also raises MMA, which limits interpretation when kidney function is poor.
What a B12 result misses at a second opinion
Confirmation needs informant history, cognitive testing, medication review, and MRI or CT to identify Alzheimer's pattern, vascular damage, tumor, or stroke. A B12 number supplies none of those details.
Longstanding neurologic symptoms may also become irreversible despite later replacement, according to the MSD Manual Professional Edition. Bring records that affect interpretation and next steps: Ask whether kidney disease could explain a high MMA before accepting it as proof of deficiency.
- diet pattern, stomach or ileal surgery, and full drug history, because metformin, proton-pump inhibitors, H2 blockers, colchicine, neomycin, and phenytoin can alter B12 results
- prior B12, folate, MMA, homocysteine, thyroid, kidney, liver, glucose, and HbA1c results with dates
- informant account of onset, examples of decline, medications, and prior MRI or CT images





